CD274 and cancer: As PD-L1 is a checkpoint inhibitor molecule that is often upregulated by cancer cells to promote immune evasion [35], additional experiments were performed to confirm if the observed increase is due to increased immune signaling (i.e., cytokine secretion from immune cells) or if it is a more direct effect of NUC-3373.